Technology, Consumer Staples, Healthcare Jan 07, 2022 06:50 PM (GMT+8) · EqualOcean
Financial Associated Press, Jan. 7 (Xinhua) -- the CSRC solicited public opinions on the guidelines on the contents and format of the prospectus of companies engaged in drug and medical device business, required to avoid using general and template expressions, and required the issuer to disclose specific risk factors in combination with industry characteristics and its own business, such as uncertain entry of products into the national medical insurance catalogue The products are included in the key drug monitoring catalogue, etc. If the issuer has not made profits or has accumulated outstanding losses, it shall disclose the relevant risks in combination with the company's core product R & D progress, product market space, liquidity arrangement, etc.

This text is a result of machine translation.

Related companies：